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Abstract 
The interactions between bovine serum albumin (BSA) and ibuprofen (IBU) were 
investigated at pH 3.0 and pH 7.4 by several two-(2D) and three-(3D) dimensional techniques 
to provide quantitative, kinetic and thermodynamic data on the BSA-IBU binding. Based on 
the results, the preparation of BSA-IBU composite nanoparticles (NPs) were successfully 
carried out for controlled drug release. The high resolution transmission electron microscopy 
(HRTEM), dynamic light scattering (DLS) and small angle x-ray scattering (SAXS) studies 
confirm the formation of nearly monodisperse NPs with daverage = 10-13 nm depending on the 
protein concentrations and IBU contents. The kinetics of pH-induced drug release was studied 
by a vertical diffusion cell at pH 7.4 at 25 
o
C. The pH-dependent changes in the secondary 
structure of BSA were proven by SAXS, DLS and surface plasmon resonance (SPR) 
investigations. Depending on the protein conformations, the SPR results suggest that the 
bonded amounts of the drug molecule are 1239 mg IBU/g BSA and 174 mg IBU/g BSA at 
acidic and neutral pH, respectively. Besides quantification of the interactions, the rate of 
association (ka) and dissociation (kd), the KA and KD standard equilibrium constants and the 
binding free energy (ΔG°) were also calculated on the basic of SPR measurements. The ΔG° = 
-21.5 ± 0.2 kJ mol
-1
 obtained by SPR in 2D system is in good agreement with the ΔG° = -
17.38 ± 0.54 kJ mol
-1
 determined by isotherm titration calorimetry (ITC) in solution (3D).  
*Manuscript
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1. Introduction 
Nanoscale drug delivery systems have been under investigations for several decades [1-3]. At 
present, numerous types of NPs are designed as feasible candidates for gene therapy and 
molecular imaging [4], but only very few have actually to mature to clinical applications. 
Polymer-, dendrimer-, lipid-, iron oxide-, quantum dots- or other organic- and inorganic-based 
NPs are synthesized in order to deliver a drug to the right place at the right time in adequate 
concentration [5-8]. The proteins are also widely used for encapsulation and transportation of 
different drug molecules. The albumin-(BSA or HSA)-based NPs play a determinant role in 
the development of novel nanocarrier systems because many binding sites are available to 
several drug molecules. Moreover, the albumins have various specific advantages in nano-
scale range, such as biodegradability, biocompatibility and non-toxicity [8]. In the interest of 
the development of an effective drug delivery systems the interaction between the drug and 
the carrier should be strong enough to facilitate the transport but also weak enough to release 
the drug to the target. Thus, the quantitative study of the binding thermodynamics and the 
knowledge of the kinetics of the release process are necessary [9]. Contrary to the (radio)-
labelled techniques in recent years a number of “label-free” techniques have been developed 
to report biomolecular interactions [10-12]. Two-dimensional SPR is a label-free technique 
and capable of measuring real-time quantitative binding affinities and kinetics for proteins 
interacting with biomolecules using relatively small (in nanomolar range) quantities of 
materials and has potential to be medium-throughput [13-15]. The conventional SPR 
technique requires that one binding component to be immobilised on a sensor chip while the 
other binding component in solution is flowed over the sensor surface; a binding interaction is 
detected using an optical method that measures remarkably small changes in refractive index 
at the sensor surface. By using this biosensor assay not only quantitative and kinetic 
information can be obtained, but the thermodynamic state functions of the interactions as well 
[16,17] because the experiments are carried out at different temperatures.  
In the present work, BSA-IBU composite NPs were prepared at pH 3.0 for pH-induced 
controlled drug release and kinetics of the ibuprofen release process at pH 7.4 was studied in 
in vitro experiments. Since the preparation of composite NPs was carried out at pH 3.0 and 
the drug release was measured at pH 7.4 the interactions between the protein and drug 
molecule were investigated at the above mentioned two pH values by using several 2D and 
3D techniques in order to provide deeper information on the binding and release processes. 
SPR and SAXS measurements were carried out to study the size and the structure of the 
nanosized particles and to determine the binding capability of protein at different pH. The 
thermodynamic binding constant (Kb), the state functions (ΔG°, ΔH°, ΔS°) and also the 
stoichiometry of the interaction (n) were determined by ITC [18], while the rate of association 
and dissociation and the KA and KD standard equilibrium constants were calculated by fitting 
of the SPR sensorgrams. The calculated kinetic constants obtained by SPR in 2D systems 
were compared with the results of the IBU release process measured in aqueous solution (3D).  
2. Materials and Methods 
2.1 Materials 
All chemicals and solvents were of analytical grade and were used without further 
purification. The  BSA  (fraction  V),  the  IBU  (C13H18O2) and the components  of  the 
McIlvaine’s buffer (pH 3.0) and the phosphate buffer (PBS, pH 7.4) were purchased from 
Sigma Aldrich, the sodium chloride (NaCl), the sodium sulphate (Na2SO4), the  sodium 
hydroxide  (NaOH)  and  the  hydrogen chloride  (HCl)  from  Molar  Chemicals.  The stock 
solutions were freshly prepared, using Milli-Q ultrapure water (18.2 MΩ cm at 25 °C).  
2.2 Preparation of BSA-IBU nanocomposite particles 
The studied nanosized protein-non steroidal anti-inflammatory (NSAID) composites were 
prepared according to the procedure published previously [19,20]. Briefly, 20 w/v% BSA was 
dissolved in 15 ml buffer solution (McIlvaine buffer, pH 3.0). When it completely dissolved 
IBU molecules were added to the BSA solution with continuous stirring in 1:1 and 1:10 molar 
ratios. We have stirred the solution for two additional hours at room temperature in order to 
form the BSA-IBU nanocomposites since more and more drug binding results more and more 
dissolved drug molecules. The BSA-IBU NPs were precipitated by 2M Na2SO4. The product 
was obtained by freeze drying (lyophilized) after centrifugation (15000 rpm, 15 min). 
2.3 HRTEM, DLS and SAXS measurements 
HRTEM images were taken by a FEI Tecnai G
2
 20 X-TWIN microscope with tungsten 
cathode at 200 kV. The parallel DLS measurements were performed with a Horiba, 
Nanopartica SZ-100 Nanoparticle Analyzer (He-Ne laser with 532 nm wavelength) in order to 
determine the size of NPs. Small angle X-ray scattering (SAXS) were used to analyze the 
morphology, size and inner structure of the prepared composites and also to study the 
conformation change of BSA at acidic and neutral pH values.  SAXS  curves  were  recorded  
with  a  slit-collimated  Kratky  compact  small-angle  system (KCEC/3  Anton-Paar  KG, 
Graz, Austria)  equipped  with  a  position-sensitive detector  (PSD  50M  from  M.Braun  
AG. Munich, Germany).  Cu Kα radiation was generated by a Philips PW1830 X-ray 
generator operating at 40 kV and 30 mA.  
2.4. SPR investigations 
SPR measurements were carried out to determine the size and the orientation of BSA 
adsorbed on the gold chip, and the binding capability of IBU on the BSA-functionalized gold 
surface at pH 3.0 and pH 7.4. A two-channel SPR sensor platform developed at the Institute 
of Photonics and Electronics (Prague) was used. The SPR chip is a thin gold layer (50 nm 
thick) deposited on a glass substrate. During investigations, a flow rate of 25 µl·min
− 1
 was 
applied at constant temperature (+20±0.1 
o
C). The interaction of IBU with the BSA was 
studied in the concentration range 5.0-40.0 μM in PBS solution at pH 3.0 and 7.4 under 
physiological conditions (150 mM NaCl). Parallel measurements were performed and the 
standard deviations of the sorption experiments were ± 4.5%. In each step, 500 μl BSA (c = 
50 μM) and 500 μl IBU solutions (c = 5.0; 10.0; 20.0; 30.0; 40.0 μM) were injected and the 
sorption process (~ 20 min) was followed by rinsing with buffer. The SPR sensorgrams were 
analyzed in real time by a special software package that allows determination of the resonant 
wavelength in both sensing channels. Based on the results of 2D SPR experiments, the rate of 
association and dissociation, the corresponding equilibrium constants and certain 
thermodynamic state functions were determined according to the following evaluation 
process. If the small molecules bind to the immobilised proteins, there is an association phase 
during which binding sites become occupied and the positive slope of SPR curve can be used 
to measure the rate of association (ka). When steady-state is achieved the RIU (refractive 
index unit) value corresponds to the changed final critical angle (angle modulated type) or the 
final wavelength of maximal plasmonic loss (wavelength modulated type). This maximum 
RIU value relates to the concentrations of immobilised protein and analyte molecules and so 
can be used to measure the binding affinity constant (KD = kd/ka). When small molecules are 
removed from the continuous flow there is a dissociation phase during which binding sites 
become unoccupied and the (negative slope) of curve can be used to measure the rate of 
dissociation (kd). 
2.5. ITC studies 
Thermometric titrations were also performed using a MicroCal VP-ITC (Isothermal Titration 
Calorimeter, MicroCal, USA) power compensation microcalorimeter with a cell volume of 
1.4163 ml. The solutions were previously degassed by means of a vacuum degasser 
Thermovac (MicroCal, USA). Two parallel measurements were carried out. The enthalpy 
changes were recorded upon stepwise additions of BSA into the reaction cell containing 
ibuprofen from a 300 μL syringe. Aliquots of 10 ml were injected at periodic time intervals 
(10 s per injection, 5 min between injections). Blank experiments were performed in order to 
make corrections for the enthalpy changes corresponding to the dilution of titrant. The 
enthalpograms (calorimeter power signal, P(t) = dQ/dt vs. t) were evaluated with Origin® 7 
software supplied by MicroCal. The area below each calorimeter peak i yielded a single point 
in S-shaped reaction enthalpy curve [21]: 
 
                  (1) 
 
Analysis of the S-shaped curves provided the stoichiometry (n) of the reaction, the binding 
constant (K), and the standard enthalpy of binding (H) according to the followings: 
For a ligand X binding to a single set of n identical sites on a macromolecule M: 
            (2) 
              (3) 
                 (4) 
The binding constant (K) is: 
  
              
                
 
 
        
     (5) 
                 (6) 
where  is the fraction of sites occupied by ligand X,  Xt and [X] are bulk and free 
concentration of ligand, n is the number of sites. The total heat content (Q) of the solution 
contained at fractional saturation  is: 
               (7) 
where ΔH is the molar heat of ligand binding and Mt is the bulk concentration of 
macromolecule in V0 active cell volume. The one set of sites model was applied for the curve 
fitting after removing the first titration points and substracting the reference water curve. The 
Gibbs free energy and the entropy term of the reaction was calculated via the well-known 
basic thermodynamic equations (ΔG° = -RT lnK and ΔG° = ΔH°-TΔS°).  
2.6. Release of IBU from BSA-IBU NPs 
The obtained BSA-IBU composites were dispersed in PBS solution. 1.5 ml suspension was 
filled to the vertical diffusion cell (Franz cell; HANSON CO.) above a cellulose membrane 
(Sigma-Aldrich). Owing to the pH-changes, the IBU starts to diffuse through the membrane to 
the pure PBS buffer. The concentration of the IBU was recorded by UV-1800 
spectrophotometer at 264 nm. The absorbance spectra were taken every 10 min in the first 
hour than once an hour to 500 min. Every measurement was repeated twice. 
3. Results and discussion  
3.1 The pH-dependent structure of BSA determined by DLS, SAXS and SPR experiments 
 It is well-known that the pH has a prominent role in the change of protein structure and 
the substrate binding as well [22]. The knowledge of the exact structure of the protein at 
different pH is necessary to design protein-based NPs for encapsulation of drug molecules. 
Since the BSA-IBU NPs were fabricated at pH 3.0 and the spontaneous release of IBU from 
NPs was measured at pH 7.4, the size and the structure of BSA at the previously mentioned 
pH values were studied by DLS, SAXS and the two-dimensional SPR experiments. Figure 1 
represents the Kratky (a), Guinier (b) plots and pair distance distribution functions (c) of BSA 
colloid solutions at different pH. The Kratky plot (Ih
2
 vs. h, where I is the scattering intensity 
and h is the scattering vector) representation provides information about the secondary 
structure of the protein, it is informative about both the globularity and the flexibility of the 
protein. In the case of folded globular protein, the Kratky plot will show a peak at low q 
values. If the curve does not converge to the q-axis at high q that indicates that the protein has 
a definite flexibility. Both the peak and the divergence from the q-axis refers dominantly the 
presence of a flexible folded state of the protein (Fig. 1a, pH 7.4, cBSA = 20.0 w/v %). 
Decrease in the pH causes the change of the shape of the Kratky plot (decrease of the peak, 
Fig. 1a, pH 3.0). This shape preferably indicates the formation of an unfolded state of the 
BSA. The Guinier plot (lnI vs. h
2
) (Fig. 1.b) and the pair distance distribution function 
(PDDF) (Fig. 1.c) are suitable to determine the size and morphology of the molecules. The 
radius of gyration (Rg) of the molecule can be calculated by linear fitting of the initial range 
(hRg < 1.3) of the scattering curve in lnI vs. h
2
 representation (Fig. 1b). As it can be seen the 
smaller radius of gyration (Rg = 2.02 nm) is determined for the BSA solution at pH 7.4 while 
the larger Rg value (Rg = 2.64 nm) belongs to the 20.0 w/v % BSA solution at pH 3.0. These 
data are in good agreement with the results of both Kratky and the PDDA representations as 
well. On the whole, the detailed SAXS results strongly support that the BSA has an unfolded 
(larger extension) structure at acidic pH (Fig. 1c, pH 3.0, the largest extension is 9.0 nm), 
while the formation of a flexible folded structure (smaller extension) (Fig. 1c, pH 7.4, the 
largest extension is only 6.3 nm) is confirmed at neutral pH. The DLS measurements also 
confirm the above mentioned pH-dependent structural changes of the protein. Namely, the 
measured average hydrodynamic diameter of BSA is d = 3.8±0.3 nm (polydispersity index, 
PDI = 0.344) at pH 3.0, while d = 8.2±0.2 nm (PDI = 0.221) was obtained at pH 7.4. Besides 
the classic three-dimensional techniques, two-dimensional SPR experiments were also 
performed to get deeper information on the size and structure (orientation) of BSA at different 
pH. The studied protein was immobilized onto the gold surface from aqueous solution (c = 
0.05 mM) at 25 °C. The registered SPR sensorgrams are presented in Figure 2. As it can be 
seen that 61.5 % and 70.0 % of adsorbed amount remains irreversibly bound at gold surface 
after rinsing procedure at pH 3.0 and 7.4, respectively. Most probably the protein is bonded 
onto the gold surface via cysteine residues resulting the formation of Au-S covalent bond. The 
binding of BSA on gold surface caused ΔλpH 3.0 = 2.8 nm and ΔλpH 7.4 = 4.1 nm plasmon shifts 
which correspond to the m
s
pH 3.0 = 56.5 ng cm
-2 
and
 
m
s
pH 7.4 = 86.0 ng cm
-2 
adsorbed amount of 
BSA. According to the calculation procedure published previously [15,23-25] the cross 
sectional area (am/nm
2
) of the BSA at acidic and neutral pH values was determined. It was 
found that the am for BSA is 195.4 nm
2
/protein
 
(pH 3.0) and
 
128.4 nm
2
/protein
 
(pH 7.4) on 
gold surface under the applied conditions. Taking into account that the protein covalently 
binds onto the gold sensor surface the pH-dependent changes in the secondary structure of 
BSA were proven in 2D systems as well indicating the larger cross sectional area of BSA is 
obtained at pH 3.0. On the whole, the size of the BSA at acidic and at neutral pH determined 
by SPR are in good agreement with the DLS and SAXS measurements.    
3.2. Characterization of the size of the BSA-IBU NPs by HRTEM, DLS and SAXS results 
 Based on the results of SPR experiments, BSA-IBU composite particles were 
successfully prepared at different BSA:IBU molar ratios. The Fig. 3.a shows the pair distance 
distribution functions for pure BSA and BSA:IBU NPs at 1:1 and 1:10 ratios obtained by 
SAXS. As it can be seen, the largest extension of the scattering objects continually increases 
in the admixture of IBU to BSA solution. (pure BSA: dSAXS = 9.0 nm; BSA:IBU (1:1) NPs: 
dSAXS = 10.0 nm; BSA:IBU (1:10) NPs: dSAXS = 10.5 nm). The sizes of NPs obtained by SAXS 
are in good agreement with the HRTEM images and also the parallel DLS experiments. The 
Fig. 3.c represents an image of BSA:IBU (1:10) NPs, the calculated average diameter is 
dHRTEM= 12.9 ± 0.5 nm, while the parallel DLS curves (Fig. 3.b) indicate the formation of NPs 
with dDLS= 11.8 ± 1.9 nm (average hydrodynamic diameter). 
3.3 Quantification of the interaction between BSA and IBU by SPR experiments 
The interaction of IBU with BSA were investigated by SPR to provide quantitative data 
of the protein-biomolecule bindings. In order to determine the binding capacity of IBU on 
BSA-covered gold surface the sorption/binding of IBU on protein-functionalized biosensor 
chip was investigated at +25±0.1 °C in the concentration range of 5 – 40 µM. The registered 
sensorgrams in Fig. 4. indicate that an increase in the concentration of the IBU solution from 
5 µM to 40 µM results in a larger sorbed amount on the functionalized surface at both studied 
pH (m
s
pH 3 = max. 75-80 ng cm
-2
, m
s
pH 7.4 = max. 12-15 ng cm
-2
). Moreover, the experiments 
clearly support that measurable high amount of IBU is bonded on BSA-covered gold surface 
at acidic pH than that at pH 7.4. Namely, m = 1239 mg IBU is bonded to BSA (referring to 
1.0 g serum albumin protein) at acidic pH while the bonded amount of IBU on BSA-covered 
gold surface is only 0.174 mg at pH 7.4. Most probably the availability of hydrophobic 
binding sites of BSA is more favoured for hydrophobic IBU molecules at acidic pH because 
of the unfolded structure. Because the water solubility of IBU is relatively less at pH 3.0 and 
above the concentration of 10 μM the aqueous solution is opalescent causing suddenly high 
changes in the refractive index which is highlighted with grey colour in Fig. 4. Based on this 
observation, only the effectively bound amount of IBU (signed with arrows) is used for the 
calculations. The sensorgrams also confirm that the interaction between the IBU molecules 
and the protein is fully reversible at pH 7.4 (Fig. 4. inset) because the adsorbed mass of IBU 
fell to nearly zero on rinsing. The confirmation of this reversible interaction is crucial in order 
to design potential nanocarrier composite system(s) for (controlled) drug release.  
3.4 Thermodynamic characterization of BSA-IBU system by ITC  
A representative calorimetric titration curves of IBU with BSA aqueous solution at pH 3.0 
and 7.4 were reported in Fig. 5. It was found that the interaction between IBU and BSA in 
aqueous solution both at pH 3.0 and 7.4 was exothermic process at 25 °C with H° = -22.85 ± 
0.57 kJ mol
-1
 and -19.57 ± 0.82 kJ mol
-1
, respectively. As expected, the value of n and K 
indicated higher affinity at acidic pH with significantly more IBU molecules (values 
summarized in Table 1) bound to BSA and the binding constant decreased from 3620 ± 89 M
-
1
 to 1110 ± 242 M
-1
 with increasing pH. The relative magnitudes of the enthalpy and entropy 
changes determine the resultant change in the Gibbs energy, which is thermodynamically 
favoured, must be negative for a spontaneous process. The values of binding constants, 
stoichiometry and the thermodynamic state functions are given in Table 1. The major driving 
force or the interaction originates from the van der Waals interaction between the BSA and 
the IBU molecules and the hydrophobic effect, the release of high energy water molecules 
from the BSA cavity. The van der Waals interactions between the host and the guest species 
are exothermic, accompanied by some entropy loss. In aqueous solution, apolar molecules are 
surrounded by water molecules with a higher hydrogen-bond density relative to the hydrogen-
bond density of pure water. Upon interaction, molecules leave the solution and break this 
hydration structure; the collapse of this “iceberg” structure is an endothermic process 
accompanied by entropy production.  
3.5 Kinetic studies in 2D and in 3D systems  
Since the SPR signal responds directly to the amount of bound ligand in real time, it 
provides a very powerful technique to study protein-ligand or any other biomolecular 
interaction thermodynamics and kinetics. The protein-based nanocomposite containing IBU 
was prepared at pH 3.0, but the release of the drug was measured at pH 7.4 under 
physiological conditions. Based on it, the SPR sensorgrams registered at pH 7.4 was used for 
detailed kinetic calculations. Assuming the A+B↔AB type reversible process is first-order 
for each reactants in the association phase and the dissociation is also first-order thus the 
following overall rate low can be given:  
     
  
                      (8) 
where [B] is the concentration of immobilized protein and [A] is the concentration of the 
aqueous IBU solution, while the [AB] is the surface concentration of the BSA-IBU complex.  
According to the research work of O’Shannessy et al. [26] integrated rate law in the 
association process shows first order growth for the complex: 
             
            (9) 
where the observed rate constant is: 
                    (10) 
 
In the dissociation phase, when only buffer is flowing over the BSA-covered gold surface, 
([A]0≈0) the concentration of BSA-IBU complex decreases exponentially with a dissociation 
rate constant: 
           
          (11) 
 
A reasonable assumption is that the Δλ reading is proportional to the concentration of bound 
complex, Δλ = α [AB]. Since the maximum concentration of the complex is [AB]max = [B]0, 
we can determine the maximum Δλ value, Δλmax = α [AB] = α [B]0. Multiplying the Eq. (9) 
and (11) by the proportional factor (α) the following equations for association and 
dissociation reactions can be given:  
            
            (12) 
         
          (13) 
 
Based on Eq. (12-13) and the registered sensorgrams, the rate constants were determined by 
using nonlinear regression process. The Fig. 6.a shows the measured (black) and the fitted 
(grey) sensorgrams. Rate constant of association and dissociation process can be determined 
from the slope and the intercept of the observed rate constant vs. concentration of the aqueous 
IBU solution plot (not presented here) according to Eq. (10). Linear regression analysis of the 
previously mentioned kobs vs. cIBU plot results the following parameters: ka = 128 ± 9 M
-1
s
-1
, kd 
= 0.02 ± 0.04 s
-1
, KA = 5965 ± 420
 
M
-1
 and ΔG° = -21.5 ± 0.2 kJmol-1. As it can be seen, if we 
use linear regression the intercept (kd) have high standard deviation. To avoid this uncertainty 
the rate constant of dissociation was extracted from exponential curve fitting to Eq. (13) (Fig. 
6.a). In this case the dissociation rate constant obtained by the nonlinear regression is kd = 
6.1×10
-3 
± 3.7×10
-4
 s
-1
. Despite of the above mentioned uncertainty of kd, the calculated value 
for the Gibbs free energy (ΔG°) obtained by linear regression analysis shows good agreement 
with the ITC experiments (Table 1). Namely, the Gibbs free energy of BSA-IBU complex 
formation at pH 7.4 is ΔG° = -21.5 ± 0.2 kJmol-1 based on the observed rate constant using 
kinetic analysis while ΔG° = -17.38 ± 0.54 kJmol-1 is determined according to ITC result.1 
                                                          
1 The Gibbs free energy of BSA-IBU complex formation originates from the difference between the 
Gibbs free energy of the unbounded state (before binding) and the saturated state (after binding). 
The release of the IBU from the composite NPs was measured in aqueous solution by using 
vertical diffusion cell at 25 
o
C. The registered release profile was shown in Fig. 6.b. As it can 
be seen that the release process starts slower in the case of the 3.9 w/v % sample [19] but after 
500 min the dissolved amount of the IBU became equal. Various kinetic models (presented in 
Table 2) were applied to describe the release mechanism of the IBU from NPs. The 
correlation coefficient (R
2
) and   the   release rate (kd) values at 25 
o
C are summarized in 
Table 2.  The R
2
 values indicate the accuracy of the applied kinetic model. Although the 
release profiles run same way, the release mechanism is definitely different. If we use BSA in 
lower concentration - the protein-drug molar ratio is same in both cases - the release of the 
drug molecule is independent on its concentration. If the BSA concentration is higher the 
release mechanism follows very well the first-order rate model, which means that the drug 
release rate depends on its concentration. The results show that the release mechanism of the 
drug can be influenced by the BSA concentration, not only by forming shells around the 
protein core.      
4. Conclusion  
The design of novel nanocarrier composite systems plays an important role in different 
pharmaceutical developments. In order to produce potent nanosized composite particles 
including drug molecules the holistic characterization of the interactions between the carrier 
material(s) (e.g. proteins) and the drug agent(s) are crucial. Besides quantification of the 
interaction, the quantitative study of the binding thermodynamics and the knowledge of the 
kinetics of the drug release process are necessary. However numerous research group focus 
their studies on the characterization of biomolecular interactions by SPR or ITC 
measurements, we successfully used the two-dimensional SPR technique for kinetic and 
thermodynamic evaluations draw a parallel between the results of individual measuring 
techniques and theories using in 3D systems. We confirmed that the important physical-
chemical parameters of a protein-drug molecule interactions obtained by SPR are in good 
agreement with the results of the classic three-dimensional SAXS, DLS, ITC and release 
studies in solution. Based on the experimental results (quantitative, kinetic and 
thermodynamic data) of this sensor technique our work may contribute to the development of 
novel nanosized drug-carrier NPs.  
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Figure captions 
Figure 1. Kratky (a), Guinier (b) plots and pair distance distribution function (c) of aqueous 
BSA solutions at pH 3.0 and 7.4. cBSA = 20 w/v %. 
Figure 2. Representative SPR sensorgrams of the binding of BSA onto gold surface at 
different pH (cBSA = 50 μM, I = 150 mM (NaCl) in PBS, T = 25 °C, flow rate of 25 µL min
-1
). 
Figure 3. PDDA representations of BSA, BSA:IBU 1:1 and 1:10 NPs (a),  the parallel DLS 
distribution functions (b) and a representative HRTEM image of BSA:IBU 1:10 NPs (c) at pH 
3.0. 
Figure 4.  Representative SPR sensorgrams of the binding of IBU onto the BSA-
functionalized gold surface at pH 3.0 and pH 7.4 (inset) (I = 150 mM (NaCl) in PBS, T = 25 
°C, flow rate of 25 µL min
-1
). 
Figure 5. Representative calorimetric titration curves of IBU with BSA solution at pH 3.0 (a) 
and 7.4 (b) at 25 °C. 
Figure 6. The measured (black) and the fitted (grey) sensorgrams to evaluate the kinetics of 
BSA-IBU interaction at pH 7.4 under physiological conditions (a) and the release profile of 
the IBU from the NPs at 25 °C at pH 7.4 (b).  
Table 1. Thermodynamic state functions, stoichiometry and binding constants determined 
from ITC and SPR measurements (T = 25 °C). 
Table 2. The rate of dissociation (kd) for the IBU at 25 °C by SPR (2D) and by release studies 
in solution (3D). 
  
Table 1. 
#
 the values were determined by ITC experiments according to Fig. 5. (mg IBU/g BSA). 
*
 on BSA-covered gold surface (mg IBU/g BSA) using cIBU = 30 µM.  
 
  
BSA-IBU 
interaction 
bonded 
amount of 
IBU 
KA  
(dm
3
 mol
-1
) 
n ΔH°  
(kJ mol
-1
) 
ΔG°  
(kJ mol
-1
) 
TΔS°  
(kJ mol
-1
) 
ITC pH 3.0 45.9 mg
#
 3.62×10
3
±89 22.1±0.1 -22.85±0.57 -20.31±0.06 -2.54±0.57 
 
pH 7.4 40.5 mg
#
 1.11×10
3
±242 10.3±0.5 -19.57±0.82 -17.38±0.54 -2.19±0.98 
SPR pH 7.4 174 mg
*
 5.97×10
3
±420 n.i. n.i. -21.5±0.2 n.i.  
Table 2. 
IBU release  kinetic models  3.9 % BSA-IBU 20.0 % BSA-IBU 
Drug release kinetics 
in solution (3D) 
zero-order (s
-1
) 
(independent from 
concentration) 
kd 6.48×10
-2
±5.6×10
-4
 1.38×10
-1
±5.2×10
-3
 
R
2
 0.990  0.984  
first-order (s
-1
) 
(dependent upon the 
concentration) 
kd 1.50×10
-3
±9.9×10
-4
 2.40×10
-3
±1.4×10
-4
 
R
2
 0.989  0.995  
Higuchi (s
-1/2
) 
(diffusion-controlled) 
kd 6.07×10
-1
±1.2×10
-1
 3.65×10
0
±7.8×10
-4
 
R
2
 0.964  0.992  
SPR kinetic 
experiments  
(2D)  
first-order (s
-1
) 
(dependent upon the 
concentration) 
kd 6.09×10
-3
±3.65×10
-4
 
R
2
 0.964 
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